about
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cellsA direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs diseaseMolecular analysis of behavior by gene transfer into neurons with herpes simplex vectors.APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cellsGene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors.An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challengeHerpesvirus/retrovirus chimeric vectors.HSV as a vector in vaccine development and gene therapy.Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer.Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharideSpecific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: protection studies against lethal viral infection in mice.A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells.Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant.Herpes simplex virus growth, preparation, and assay.An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency.Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors.Herpes simplex virus type 1 uracil-DNA glycosylase: isolation and selective inhibition by novel uracil derivatives.Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection.Herpes simplex virus and human cancer. II. Search for relationship between labial tumours and Herpes simplex type 1.Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses.Replication-competent herpes simplex virus type 1 mutant expressing an autofluorescent glycoprotein H fusion protein.Characterization of virus obtained from MDBK cells persistently infected with a variant of herpes simplex virus type 1 strain MP [HSV-1(MP)].Constitutive expression in human cells of herpes simplex virus type 1 glycoprotein B gene cloned in an episomal eukaryotic vector.L-thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth.Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo.Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model.Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes.Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activityLocal and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infectionAntitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growthExperimental keratitis in rabbits by human HSV-1 variants: prevention and treatmentAnalysis of HSV isolated from patients with unilateral and bilateral herpetic keratitisEffects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitisRed blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice
P50
Q28239286-8B0E349B-A710-4C37-A313-F30BB8212D9BQ29395388-E33A25EA-87AD-40F5-9997-EDBDB0932D3DQ33711544-54313FA9-FB2B-4ED6-9BA6-74AD135F84F8Q33749923-2B63B02B-1888-4068-87E2-3A5620E12707Q33899454-8E38927B-3BB2-4308-B892-6B11A4134D42Q33916162-8C3C1DEE-1D58-48F6-830D-733A743EBC73Q35972133-28ECA459-5926-475C-8F7F-3DCC47BDB1B1Q37170406-52AA5C05-9E14-4F0B-BF81-806634C70D5CQ39441540-2072DD19-33A4-47BE-92B6-75BCFD0303E1Q39968970-01ADD6E4-A389-454B-8DDB-1FD7868F866AQ40571240-02063B20-56EA-41C0-AA8E-9EB0694F47C9Q41261332-57373AC8-8EC2-47B9-946F-D5EBED061AA3Q41397184-C315DB1B-7812-48F1-A5C7-40B05456D12EQ41512503-3885CC5F-66C8-4C07-B510-F74BE1BEF771Q42228910-6A0C1069-274B-40CC-B64E-754A4AC46B27Q42375328-A31012B8-476A-46AE-A361-F28D5E854D73Q42793390-D05A322B-5E89-494F-B382-E3B1E5CAA963Q42809433-B4E73639-422F-494F-9801-F34DEE6578C0Q43707263-265A7F2C-9D3C-407F-8864-274B448718D3Q44029225-0413B639-9236-4ED1-BF22-7223CA387BFCQ45413779-D931FE3D-F6C5-4772-A631-08DEBBE9AC7CQ45736047-BD151833-7136-48E3-9CF7-6D1F60F6E778Q45837522-3BAAAB29-F364-42F8-B93C-4AD6083EC9F3Q45840766-1F962280-E9B0-4EB7-96BC-DC2DD162F0E8Q45876658-597940F0-B0D8-483F-8C18-EE9050E5B630Q45880231-579B71B5-EA0F-4DF9-9FF9-19EC05747D83Q46606593-E9B8E894-A098-498B-9D05-23D2BDFE2235Q47442370-E8258157-FCEF-495B-9F16-E7FD1E74A701Q57951216-B466631C-ACD0-46D4-BF9B-94BB9E74D9AEQ58620095-DF5901C9-B623-4CD0-83CA-D3FC909D0423Q62971003-EF850103-9B0E-48CA-BE7F-1215B16384E8Q68494318-3EC150CB-5015-4437-933F-7B2E47611FD6Q70092972-27DD83D7-7D2B-43A2-A4F1-0C082DF860D3Q71379200-14692E28-8037-4CBA-989D-F5A54D210B39Q73315957-10568155-BD13-4EBD-B881-DD4415B12D25
P50
description
researcher, ORCID id # 0000-0002-2827-229X
@en
wetenschapper
@nl
name
Roberto Manservigi
@ast
Roberto Manservigi
@en
Roberto Manservigi
@es
Roberto Manservigi
@nl
type
label
Roberto Manservigi
@ast
Roberto Manservigi
@en
Roberto Manservigi
@es
Roberto Manservigi
@nl
prefLabel
Roberto Manservigi
@ast
Roberto Manservigi
@en
Roberto Manservigi
@es
Roberto Manservigi
@nl
P106
P1153
7003788335
P21
P31
P496
0000-0002-2827-229X